Biocon
Biocon is an Indian biopharmaceutical company. It was founded in 1978 by Kiran Mazumdar-Shaw. Its headquarters are in Bengaluru.
- Founded
- 1978
- Founded by
- Kiran Mazumdar-Shaw
- Headquarters
- Bengaluru
- Industry
- biotechnology
- Country
- India
All 8 facts, and where they come from
Facts
8 facts · 0 confirmed by two sources · 2 cited · 5 from one source · 1 where the sources disagree
What’s different
- Founded: we show 1978 (Sources disagree). Wikidata also lists November 29, 1978
Where this comes from
Papalocal keeps its own record. It started from these sources; what each one said is kept here as it was copied, so a change on their side never changes this page by itself. Tap one to read its version.
What Wikidata says · copied November 17, 2026 · revision 2563312972
- Described as
- an Indian biopharmaceutical company
- Other names
- Biocon Ltd.
- What it is
- business; public company
- Founded
- 1978 · 1 reference; November 29, 1978 · 1 reference
- Founded by
- Kiran Mazumdar-Shaw · 1 reference
- Headquarters
- Bengaluru
- Country
- India · 1 reference
- Industry
- biotechnology
- Official website
- http://www.biocon.com/ · 1 reference
- Wikipedias with a page
- 10
Wikidata item Q487694 (wikidata.org/wiki/Q487694), public domain (CC0). Copied 2026-11-17.
What Wikipedia says · copied November 17, 2026 · revision 1383414250
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN (rh-insulin), BASALOG (Glargine), BIOMAb EGFR (Nimotuzumab), BLISTO (Glimepiride + Metformin), CANMAb (Trastuzumab), Evertor (Everolimus), TACROGRAF (Tacrolimus), ALZUMAb (Itolizumab) and KRABEVA (Bevacizumab).
Syngene International Limited (Syngene) is a publicly listed subsidiary of Biocon, operating in the contract research and development organization.
From the Wikipedia article “Biocon” (en.wikipedia.org/wiki/Biocon), by its contributors, under CC BY-SA 4.0 (creativecommons.org/licenses/by-sa/4.0/). Copied 2026-11-17; not changed.
Confirmed Two sources agree. Cited One source, and it names where it got it. One source One source, without a reference of its own. Sources disagree The sources disagree. We show the best-supported value and keep theirs below.
